التفاصيل البيبلوغرافية
| العنوان: |
Spectrum of mutations and genotype-phenotype analysis in Noonan syndrome patients with RIT1 mutations. |
| المؤلفون: |
Yaoita, Masako, Niihori, Tetsuya, Mizuno, Seiji, Okamoto, Nobuhiko, Hayashi, Shion, Watanabe, Atsushi, Yokozawa, Masato, Suzumura, Hiroshi, Nakahara, Akihiko, Nakano, Yusuke, Hokosaki, Tatsunori, Ohmori, Ayumi, Sawada, Hirofumi, Migita, Ohsuke, Mima, Aya, Lapunzina, Pablo, Santos-Simarro, Fernando, García-Miñaúr, Sixto, Ogata, Tsutomu, Kawame, Hiroshi |
| المصدر: |
Human Genetics; Feb2016, Vol. 135 Issue 2, p209-222, 14p |
| مصطلحات موضوعية: |
NOONAN syndrome, MUSCULOSKELETAL system abnormalities, CONGENITAL heart disease, GENETIC mutation, HYPERTROPHIC cardiomyopathy, ATRIAL septal defects, PULMONARY stenosis, SHORT stature |
| مستخلص: |
RASopathies are autosomal dominant disorders caused by mutations in more than 10 known genes that regulate the RAS/MAPK pathway. Noonan syndrome (NS) is a RASopathy characterized by a distinctive facial appearance, musculoskeletal abnormalities, and congenital heart defects. We have recently identified mutations in RIT1 in patients with NS. To delineate the clinical manifestations in RIT1 mutation-positive patients, we further performed a RIT1 analysis in RASopathy patients and identified 7 RIT1 mutations, including two novel mutations, p.A77S and p.A77T, in 14 of 186 patients. Perinatal abnormalities, including nuchal translucency, fetal hydrops, pleural effusion, or chylothorax and congenital heart defects, are observed in all RIT1 mutation-positive patients. Luciferase assays in NIH 3T3 cells demonstrated that the newly identified RIT1 mutants, including p.A77S and p.A77T, and the previously identified p.F82V, p.T83P, p.Y89H, and p.M90I, enhanced Elk1 transactivation. Genotype-phenotype correlation analyses of previously reported NS patients harboring RIT1, PTPN11, SOS1, RAF1, and KRAS revealed that hypertrophic cardiomyopathy (56 %) was more frequent in patients harboring a RIT1 mutation than in patients harboring PTPN11 (9 %) and SOS1 mutations (10 %). The rates of hypertrophic cardiomyopathy were similar between patients harboring RIT1 mutations and patients harboring RAF1 mutations (75 %). Short stature (52 %) was less prevalent in patients harboring RIT1 mutations than in patients harboring PTPN11 (71 %) and RAF1 (83 %) mutations. These results delineate the clinical manifestations of RIT1 mutation-positive NS patients: high frequencies of hypertrophic cardiomyopathy, atrial septal defects, and pulmonary stenosis; and lower frequencies of ptosis and short stature. [ABSTRACT FROM AUTHOR] |
|
Copyright of Human Genetics is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
